Keyphrases
Cervical Cancer
100%
Early Indicators
100%
Squamous Cell Carcinoma Antigen
100%
SCCA1
45%
Definitive Chemoradiation Therapy
27%
Tumor Cell Lines
18%
Cervical Tumor
18%
FDG PET-CT
18%
Treatment Response
9%
Immunohistochemistry
9%
Chemoradiation Therapy
9%
Overall Survival
9%
Molecular Targets
9%
Knock
9%
Clonogenic Survival
9%
Antigen Targeting
9%
Radiosensitivity
9%
Early Response
9%
Tumor Biopsy
9%
Cervical Carcinoma
9%
Prognostic Biomarker
9%
Prognostic Tool
9%
Molecular Role
9%
Radiation Response
9%
Radiation Resistance
9%
SCCA2
9%
De-escalation Therapy
9%
CRISPR-Cas9 Knockout
9%
SerpinB3
9%
Serpin B4
9%
Increased Radioresistance
9%
Medicine and Dentistry
Cervical Cancer
100%
Squamous Cell Carcinoma Antigen
100%
Chemoradiation Therapy
36%
Radiosensitivity
27%
Positron Emission Tomography-Computed Tomography
18%
Tumor Cell Line
18%
Recurrent Disease
18%
Biological Marker
9%
Treatment Response
9%
Immunohistochemistry
9%
In Vitro
9%
Overall Survival
9%
Tumor Biopsy
9%
Carcinoma
9%
Knock Out
9%
Clustered Regularly Interspaced Short Palindromic Repeat
9%
Radiation Response
9%
Cas9
9%
Pharmacology, Toxicology and Pharmaceutical Science
Uterine Cervix Cancer
100%
Squamous Cell Carcinoma Antigen
100%
Chemoradiation Therapy
36%
Neoplasm
27%
Recurrent Disease
18%
Polyethylene Terephthalate
18%
Biological Marker
9%
Overall Survival
9%
Squamous Cell Carcinoma
9%
Biochemistry, Genetics and Molecular Biology
Radiosensitivity
100%
Positron Emission Tomography-Computed Tomography
66%
CRISPR/Cas9
33%
Overall Survival
33%
Isoform
33%